Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
STIM Neuronetics Inc
- Stocks
- Healthcare
- NASDAQ: STIM
Price (delayed)
$4.22
Market cap
$277.76M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.32
Enterprise value
$339.08M
Neuronetics, Inc. is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its commercial
Highlights
STIM's equity is up by 28% year-on-year and by 28% since the previous quarter
The revenue has grown by 22% YoY and by 19% from the previous quarter
Neuronetics's quick ratio has plunged by 59% YoY but it has increased by 38% from the previous quarter
STIM's EPS is down by 39% YoY but it is up by 4.3% from the previous quarter
The net income has plunged by 76% YoY and by 11% from the previous quarter
The company's debt rose by 32% YoY
Key stats
What are the main financial stats of STIM
Market
Valuations
Earnings
Shares outstanding
65.82M
Market cap
$277.76M
Enterprise value
$339.08M
Price to earnings (P/E)
N/A
Price to book (P/B)
7.83
Price to sales (P/S)
2.9
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.79
Revenue
$89.45M
Gross profit
$56.81M
Operating income
-$38.72M
Net income
-$48.51M
EBIT
-$41.13M
EBITDA
-$38.7M
Free cash flow
-$37.29M
Per share
Balance sheet
Liquidity
EPS
-$1.32
EPS diluted
-$1.32
Free cash flow per share
-$0.61
Book value per share
$0.54
Revenue per share
$1.46
TBVPS
$1.69
Total assets
$141.99M
Total liabilities
$102.46M
Debt
$82.54M
Equity
$35.45M
Working capital
$35.83M
Debt to equity
2.33
Current ratio
2.44
Quick ratio
1.95
Net debt/EBITDA
-1.58
Margins
Efficiency
Dividend
EBITDA margin
-43.3%
Gross margin
63.5%
Net margin
-54.2%
Operating margin
-43.3%
Return on assets
-42.8%
Return on equity
-211.1%
Return on invested capital
-36.7%
Return on capital employed
-35.1%
Return on sales
-46%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
STIM stock price
How has the Neuronetics stock price performed over time
Intraday
-1.86%
1 week
-4.74%
1 month
11.94%
1 year
67.46%
YTD
162.11%
QTD
14.67%
Financial performance
How have Neuronetics's revenue and profit performed over time
Revenue
$89.45M
Gross profit
$56.81M
Operating income
-$38.72M
Net income
-$48.51M
Gross margin
63.5%
Net margin
-54.2%
The net income has plunged by 76% YoY and by 11% from the previous quarter
The company's net margin fell by 44% YoY but it rose by 7% QoQ
STIM's operating income is down by 41% YoY and by 12% from the previous quarter
The revenue has grown by 22% YoY and by 19% from the previous quarter
Price vs fundamentals
How does STIM's price correlate with its fundamentals
Growth
What is Neuronetics's growth rate over time
Valuation
What is Neuronetics stock price valuation
P/E
N/A
P/B
7.83
P/S
2.9
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.79
STIM's EPS is down by 39% YoY but it is up by 4.3% from the previous quarter
STIM's price to book (P/B) is 180% more than its 5-year quarterly average of 2.8 and 124% more than its last 4 quarters average of 3.5
STIM's equity is up by 28% year-on-year and by 28% since the previous quarter
The P/S is 164% above the last 4 quarters average of 1.1 and 38% above the 5-year quarterly average of 2.1
The revenue has grown by 22% YoY and by 19% from the previous quarter
Efficiency
How efficient is Neuronetics business performance
The ROE has plunged by 178% YoY
The return on assets has dropped by 60% year-on-year
STIM's ROIC has plunged by 56% YoY and by 3.7% from the previous quarter
STIM's ROS has plunged by 56% YoY but it is up by 5% from the previous quarter
Dividends
What is STIM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for STIM.
Financial health
How did Neuronetics financials performed over time
The total assets is 39% more than the total liabilities
Neuronetics's quick ratio has plunged by 59% YoY but it has increased by 38% from the previous quarter
STIM's current ratio has plunged by 57% YoY but it is up by 31% from the previous quarter
The company's debt is 133% higher than its equity
The company's debt rose by 32% YoY
STIM's equity is up by 28% year-on-year and by 28% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.